Breastoz 2.5 (Letrozole 2.5 mg) is an aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By inhibiting the aromatase enzyme Letrozole effectively reduces estrogen levels in the body slowing the growth of estrogen-dependent tumors. Breastoz 2.5 is often prescribed as part of a comprehensive treatment plan either as an initial therapy or in patients who have experienced a recurrence providing critical support in managing breast cancer.
Reviews
There are no reviews yet.